Fund Holdings — Rosalind Advisors, Inc.

Total Portfolio Value:
$309.26M
Total Bought:
$68.51M
Total Sold:
$34.11M
Net Transaction:
+$34.40M
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Delcath Systems, Inc.(DCTH)3,300,3893,300,3890$41.55M$52.71M17.04%+$11.16M
Verastem, Inc.(VSTM)3,986,5094,236,509+250,000$15.23M$34.10M11.03%+$18.88M
Fennec Pharmaceuticals Inc.(FENC)3,188,0013,188,0010$34.27M$33.95M10.98%-$318.8K
Xeris Biopharma Holdings Inc2,908,9812,582,647-326,334$23.04M$24.69M7.98%+$1.65M
Helus Pharma Inc(HELP)1,956,8141,387,969-568,845$12.93M$17.06M5.52%+$4.12M
Savara Inc.(SVRA)3,178,1213,178,1210$19.58M$16.40M5.30%-$3.18M
Replimune Group, Inc.(REPL)01,000,000+1,000,000$0$13.24M4.28%+$13.24M
Vor Biopharma Inc.(VOR)648,600609,199-39,401$11.94M$11.62M3.76%-$317.2K
MediWound Ltd.SHS NEW(MDWD)749,054749,0540$11.01M$10.31M3.34%-$696.6K
X4 Pharmaceuticals, Inc.(XFOR)3,214,7663,214,7660$15.01M$9.32M3.01%-$5.69M
Aquestive Therapeutics Inc250,0002,000,000+1,750,000$1.04M$9.26M2.99%+$8.22M
Vaxcyte, Inc.(PCVX)200,000149,361-50,639$11.63M$8.50M2.75%-$3.13M
Protara Therapeutics, Inc.(TARA)02,400,000+2,400,000$0$7.32M2.37%+$7.32M
Myomo, Inc.(MYO)3,637,8863,917,886+280,000$3.78M$6.11M1.98%+$2.33M
BioCryst Pharmaceuticals, Inc.(BCRX)721,504721,5040$7.22M$6.01M1.94%-$1.20M
Rocket Pharmaceuticals, Inc.(RCKT)02,200,000+2,200,000$0$5.79M1.87%+$5.79M
PepGen Inc.(PEPG)350,0002,000,000+1,650,000$630.0K$4.84M1.57%+$4.21M
Profound Medical Corp.(PROF)828,118828,1180$5.51M$4.80M1.55%-$703.9K
Talphera, Inc.(TLPH)5,169,5014,134,144-1,035,357$5.32M$4.80M1.55%-$529.0K
NeurAxis, Inc.(NRXS)508,055548,123+40,068$2.97M$4.04M1.31%+$1.07M
Ovid Therapeutics Inc.(OVID)1,107,9941,107,9940$2.98M$2.76M0.89%-$221.6K
InspireMD, Inc.(NSPR)3,905,7433,905,7430$2.73M$2.62M0.85%-$117.6K
Acumen Pharmaceuticals, Inc.(ABOS)01,100,000+1,100,000$0$2.44M0.79%+$2.44M
EyePoint, Inc.(EYPT)988,230695,977-292,253$14.13M$2.28M0.74%-$11.86M
ABIVAX Société AnonymeADS(ABVX)20,86920,8690$2.78M$2.07M0.67%-$714.6K
Biofrontera Inc.(BFRI)1,275,6091,789,288+513,679$1.21M$1.93M0.62%+$726.3K
Femasys Inc0759,213+759,213$0$1.64M0.53%+$1.64M
Atea Pharmaceuticals, Inc.(AVIR)1,070,550280,061-790,489$4.98M$1.46M0.47%-$3.52M
CG Oncology, Inc.(CGON)020,000+20,000$0$1.42M0.46%+$1.42M
Spruce Biosciences Inc20,00026,517+6,517$1.08M$1.29M0.42%+$208.2K
Regentis Biomaterials Ltd.(RGNT)701,685701,6850$2.48M$1.27M0.41%-$1.21M
Kura Oncology, Inc.(KURA)100,000100,0000$1.10M$1.07M0.35%-$26.0K
Grace Therapeutics, Inc.(GRCE)0476,190+476,190$0$1.02M0.33%+$1.02M
PolyPid Ltd.(PYPD)389,455177,011-212,444$1.98M$932.8K0.30%-$1.05M
OnKure Therapeutics, Inc.CL A(OKUR)150,00067,506-82,494$684.0K$184.0K0.06%-$500.0K
Celldex Therapeutics, Inc.(CLDX)200,0000-200,000$7.44M$0—-$7.44M
Page 1 of 1
Rosalind Advisors, Inc. — 13F Holdings — Q3 2026 | TickerTrail